Martin Marciniak

1.1k total citations
17 papers, 822 citations indexed

About

Martin Marciniak is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Experimental and Cognitive Psychology. According to data from OpenAlex, Martin Marciniak has authored 17 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Experimental and Cognitive Psychology. Recurrent topics in Martin Marciniak's work include Lung Cancer Treatments and Mutations (6 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Martin Marciniak is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Martin Marciniak collaborates with scholars based in United States, United Kingdom and Canada. Martin Marciniak's co-authors include Ronald Landbloom, Eduardo Dunayevich, Maureen J. Lage, Joseph Treat, Jane Bromund, Coleman K. Obasaju, James M. Russell, John F. Gill, Shaker R. Dakhil and Panos Fidias and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Nervous and Mental Disease and The Journal of Clinical Psychiatry.

In The Last Decade

Martin Marciniak

17 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Marciniak United States 13 378 362 150 139 73 17 822
Philip Twumasi‐Ankrah United States 11 368 1.0× 289 0.8× 79 0.5× 66 0.5× 25 0.3× 19 953
Dounya Schoormans Netherlands 16 173 0.5× 316 0.9× 72 0.5× 58 0.4× 45 0.6× 47 765
D. Storey United Kingdom 12 171 0.5× 541 1.5× 95 0.6× 39 0.3× 19 0.3× 22 858
Roy Nitulescu Canada 13 170 0.4× 155 0.4× 67 0.4× 38 0.3× 53 0.7× 29 797
Jacqueline Galica Canada 14 306 0.8× 528 1.5× 53 0.4× 37 0.3× 35 0.5× 52 1.0k
Sarah Dauchy France 15 206 0.5× 451 1.2× 116 0.8× 19 0.1× 25 0.3× 71 912
Heather L. McGinty United States 15 354 0.9× 697 1.9× 97 0.6× 38 0.3× 36 0.5× 18 1.1k
KS Gopinath India 10 158 0.4× 374 1.0× 221 1.5× 43 0.3× 12 0.2× 14 766
José A. E. Custers Netherlands 20 426 1.1× 789 2.2× 66 0.4× 57 0.4× 31 0.4× 64 1.2k
Jamie M. Stagl United States 13 247 0.7× 615 1.7× 130 0.9× 29 0.2× 61 0.8× 18 1.2k

Countries citing papers authored by Martin Marciniak

Since Specialization
Citations

This map shows the geographic impact of Martin Marciniak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Marciniak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Marciniak more than expected).

Fields of papers citing papers by Martin Marciniak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Marciniak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Marciniak. The network helps show where Martin Marciniak may publish in the future.

Co-authorship network of co-authors of Martin Marciniak

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Marciniak. A scholar is included among the top collaborators of Martin Marciniak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Marciniak. Martin Marciniak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Brixner, Diana, et al.. (2019). Preapproval Information Exchange: Perspectives of U.S. Population Health Decision Makers on Preferences for Early Engagement with Investigational Therapies. Journal of Managed Care & Specialty Pharmacy. 25(2). 164–173. 7 indexed citations
2.
Walker, Mark S., Gerhardt Pohl, Arthur C. Houts, et al.. (2016). Analysis of the psychological impact of cancer-related symptoms on patients with non-small cell lung cancer. Psycho-Oncology. 26(6). 755–762. 12 indexed citations
3.
Pennella, Eduardo J., Coleman K. Obasaju, Gerhardt Pohl, et al.. (2013). Prospective Observational Comparison of Clinical Outcomes Between African-American and Caucasian Patients Receiving Second-Line Treatment With Pemetrexed for Advanced Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 14(6). 726–735. 5 indexed citations
4.
Meadows, Eric S., Margaret Colby, Vivian Herrera, et al.. (2011). Out-of-Pocket Drug Costs and Drug Utilization Patterns of Postmenopausal Medicare Beneficiaries with Osteoporosis. ˜The œAmerican journal of geriatric pharmacotherapy. 9(4). 241–249. 14 indexed citations
5.
Brufsky, Adam, Karen Hoelzer, Thaddeus Beck, et al.. (2011). A Randomized Phase II Study of Paclitaxel and Bevacizumab With and Without Gemcitabine as First-Line Treatment for Metastatic Breast Cancer. Clinical Breast Cancer. 11(4). 211–220. 25 indexed citations
6.
Clements, Karen M., Gerson Peltz, Douglas E. Faries, et al.. (2010). Does Type of Tumor Histology Impact Survival among Patients with Stage IIIB/IV Non-Small Cell Lung Cancer Treated with First-Line Doublet Chemotherapy?. PubMed. 2010. 1–8. 10 indexed citations
7.
Stokes, Michael E., Catherine E. Muehlenbein, Martin Marciniak, et al.. (2009). Neutropenia-Related Costs in Patients Treated with First-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer. Journal of Managed Care Pharmacy. 15(8). 669–682. 47 indexed citations
8.
Lang, Kathleen, Martin Marciniak, Douglas E. Faries, et al.. (2009). Costs of First-Line Doublet Chemotherapy and Lifetime Medical Care in Advanced Non–small-Cell Lung Cancer in the United States. Value in Health. 12(4). 481–488. 21 indexed citations
9.
Zhu, Baojin, Zhongyun Zhao, Wenyu Ye, Martin Marciniak, & Ralph Swindle. (2009). The Cost of Comorbid Depression and Pain for Individuals Diagnosed With Generalized Anxiety Disorder. The Journal of Nervous and Mental Disease. 197(2). 136–139. 23 indexed citations
10.
Lang, Kathleen, Martin Marciniak, D Faries, et al.. (2008). Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States. Lung Cancer. 63(2). 264–270. 50 indexed citations
11.
Fidias, Panos, Shaker R. Dakhil, Alan P. Lyss, et al.. (2008). Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 27(4). 591–598. 304 indexed citations
12.
Endicott, Jean, James M. Russell, Joel Raskin, et al.. (2007). Duloxetine Treatment for Role Functioning Improvement in Generalized Anxiety Disorder. The Journal of Clinical Psychiatry. 68(4). 518–524. 31 indexed citations
13.
Pritchett, Yili, Martin Marciniak, Patricia K. Corey‐Lisle, et al.. (2006). Use of effect size to determine optimal dose of duloxetine in major depressive disorder. Journal of Psychiatric Research. 41(3-4). 311–318. 14 indexed citations
14.
Marciniak, Martin, Maureen J. Lage, Eduardo Dunayevich, et al.. (2005). The cost of treating anxiety: the medical and demographic correlates that impact total medical costs. Depression and Anxiety. 21(4). 178–184. 141 indexed citations
15.
Marciniak, Martin, Maureen J. Lage, Ronald Landbloom, Eduardo Dunayevich, & Lee Bowman. (2004). Medical and productivity costs of anxiety disorders: Case control study. Depression and Anxiety. 19(2). 112–120. 70 indexed citations
16.
Keeler, Theodore E., Teh‐wei Hu, Alison Keith, et al.. (2002). The benefits of switching smoking cessation drugs to over‐the‐counter status. Health Economics. 11(5). 389–402. 33 indexed citations
17.
Keeler, Theodore E., Martin Marciniak, & Teh‐wei Hu. (1999). Rational addiction and smoking cessation: An empirical study. The Journal of Socio-Economics. 28(5). 633–643. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip Twumasi‐Ankrah Breakdown of academic impact, for papers by Dounya Schoormans Breakdown of academic impact, for papers by D. Storey Breakdown of academic impact, for papers by Roy Nitulescu Breakdown of academic impact, for papers by Jacqueline Galica Breakdown of academic impact, for papers by Sarah Dauchy Breakdown of academic impact, for papers by Heather L. McGinty Breakdown of academic impact, for papers by KS Gopinath Breakdown of academic impact, for papers by José A. E. Custers Breakdown of academic impact, for papers by Jamie M. Stagl
Rankless by CCL
2026